online ISSN 2415-3176
print ISSN 1609-6371
logoExperimental and Clinical Physiology and Biochemistry
  • 11 of 12
Up
ECPB 2019, 87(3): 75–81
https://doi.org/10.25040/ecpb2019.03.075
Research articles

Significance оf Gas Transmitter Nitrogen Oxide аnd Nucleic Acids in the Prognosis for Patients with Severe Brain Injury

V.М. SHEVAGA, А.V. PAYENOK, А.М. NETLIUKH, Т.G. GUTOR, N.V. МATOLINETS, B.V. ZADOROZHNA, О.Ja. KOBYLETSKYI
Abstract

Introduction. Traumatic brain injury (TBI) consist one third of all traumas and is a leading cause of mortality and morbidity. The effectiveness of therapeutic measures in TBI depends primarily on the prompt diagnosis. Diagnostics include laboratory blood and urine indicators. Special place is taken by nitrogen oxide (NO) gas transmitter. The peculiarities of the NO in trauma are that it is synthesized very quickly in response to the stimuli, and upon release, enters the cell by diffusion without requiring receptors to initiate intracellular signals, and then chemically modifies the cellular targets. Important role is noted also for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA).

Objectives. To define the significance of NO gas transmitter, RNA and DNA for prognosis at the patients with severe TBI.

Methods. We analyzed the results of the diagnostics data of 72 patients with severe TBI aged 18 to 76 years (mean age 42.3 ± 15.0 years), which were divided into 4 groups according to the Glasgow Outcome scale (GOS): "Death" (1 point on GOS, 36 patients), "Significant disability" (2-3 points on GOS, 8 patients), "Moderate disability" (4 points on GOS, 18 patients), "Recovery" (5 points on GOS, 10 patients). Control group cosisted 22 practically healthy volunteers. The studies included assessing the dynamics and correlation of NO, RNA, and DNA over first 30 days of treatment.

Results. The comparison of NO values in the main groups of outcomes showed that the NO index in the “Death” group was higher than one of all other groups in almost all days (except 14th day) of observation (p<0.05). In patients of “Moderate disability” group, the level of NO was the lowest in almost all groups (p <0.05) from the 7th to the 14th day, as in the “Recovery” group - on the fifth day (p <0.05).

We noted an increase of NO in patients with lethal outcome (direct strong correlation (r = + 0.75, p <0.01)) and decrease during the intensive care in patients with moderate disability and recovery (inverse strong correlation r = -0.77, p <0.01). Overall, in patients with severe TBI, the mean level of nucleic acids tended to decline: the DNA index decreased from 8.60 ± 0.35 μg / ml on the 1st day to 6.65 ± 2.15 μg / ml on the 30th day of treatment ( p> 0.05), the RNA level decreased from 626.82 ± 13.27 to 347.00 ± 151.00 μg / ml (p <0.05). Comparison of these indicators between groups showed that the DNA level in the “Death” group was significantly higher from 9th to 14th days compared to the “Recovery” group, and in all days of the study with the control group (p <0.01); level of RNA was highest on day 14 compared with the “Recovery” group and higher for the whole observation period than in the control group (p <0.01). The highest levels of DNA at day 9 and RNA at day 14 among all other outcome groups of patients were prognosticators of poor outcome for patients in “Death” group. In mostly all days of the study, DNA and RNA levels were the lowest among all outcome groups in the patients who were recovered. Decreases in DNA and RNA levels during treatment were confirmed by strong inverse correlation of DNA and RNA contents during the observation period (r = -0.94, r = -0.93, p <0.01, respectively).

Conclusion: significant changes of biochemical parameters were observed at the patients with severe TBI: high levels of urinary NO metabolites and blood serum nucleic acids (DNA and RNA), that reliably correlated with outcomes. The results of the investigation will be useful for practitioners to assess the patient's condition and choose appropriate treatment approach, which will minimize the secondary brain traumatization and predict the outcomes of TBI.

Received: 29.08.19

Keywords: traumatic brain injury, gas transmitters, nitrogen oxide, deoxyribonucleic acid, ribonucleic acid, outcome

Full text: PDF (Ukr) 404K

References
  1. 1. Polishchuk ME, Goncharuk OM. Closed craniocerebral trauma. A modern look at the problem. International neurol magazine 2015;6(76):72-80) http.
  2. 2. Poltoratsky VG. Causes of combined craniocerebral injury. Experimental and Clinical Medicine. 2013;4(61):116-9).
  3. 3. Stupnitsky MA. Acute phase response of the early period of traumatic illness of severe combined thoracic trauma. Young scientist. 2015;11(3):94-100) http.
  4. 4. Maas A, Marmarou A, Murray G, Teasdale GM, Steyerberg EW. Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. J. Neurotrauma 2007;24:232-8. doi.org/10.1089/neu.2006.0024
  5. 5. Agarwal A, Bolisetty S. Adaptive responses to tissue injury: role of heme oxygenase-1. Trans. Am. Clin. Climatol. Assoc. 2013;124:111-22. PMID: 23874015
  6. 6. García-Mata C, Lamattina L. Gasotransmitters are emerging as new guard cell signaling molecules and regulators of leaf gas exchange. Plant Sci. 2013;201-202:66-73. doi.org/10.1016/j.plantsci.2012.11.007
  7. 7. Wang R. Shared signaling pathways among gasotransmitters, PNAS 2012;109(23):8801-2. doi.org/10.1073/pnas.1206646109
  8. 8. Ondruschka B, Schuch S, Pohlers D, Franke H, Dreßler J. Acute phase response after fatal traumatic brain injury. Int J Legal Med 2018 Jan;6. doi.org/10.1007/s00414-017-1768-2
  9. 9. Wilson NM, Gurney ME, Dietrich WD, Atkins CM. Traumatic brain injury. PLoS ONE 2017;12(5). e0178013. doi.org/10.1371/journal.pone.0178013
  10. 10. Di Perri C, Heine L, Amico E, Soddu A, Laureys S, Demertzi A. Technology-based assessment in patients with disorders of consciousness. Ann. Ist. Super Sanita. 2014;50(3):209- 20.doi.org/10.4415/ANN_14_03_03
  11. 11. Zanier ER, Zoerle T, Fiorini M, Longhi L, Cracco L, Bersano A et al. Heart-fatty acid- binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients. Br J Anaesth. 2013 Sep; 111(3):424-32.doi.org/10.1093/bja/aet149
  12. 12. Zarutsky YaL, Denisenko VM, Tkachenko AE. Features of diagnostics of combined cranioabdominal trauma. Collection of scientific works of Shupika NMAPE. 2015;24(1):52-7.
  13. 13. Tsanaev RG., Markov GG. On the issue of quantitative spectrophotometric determination of nucleic acids. Biochemistry. 1960;25(1):151-9.
  14. 14. Golikov PP, Matveev SB, Pakhomova GV, Uteshev NS, Nikolaev NU, Dorfman AG, et al. Dynamics of excretion of nitrate as the final product of nitric oxide with urine in patients with peritonitis. Klin. lab. diagnostics. 1999;9:17-8.
  15. 15. Maksymets T, Karpyshyn N, Gutor T, Sklyarova H, Sklyarov E. Influence of risk factors on insulin resistance in patients with overweight and obesity. Wiadomosci lekarskie 2018;71(3 pt 1):558-60.


Програмування - Roman.im